Cargando…
FOXP3 Is a HCC suppressor gene and Acts through regulating the TGF-β/Smad2/3 signaling pathway
BACKGROUND: FOXP3 has been discovered to be expressed in tumor cells and participate in the regulation of tumor behavior. Herein, we investigated the clinical relevance and biological significance of FOXP3 expression in human hepatocellular carcinoma (HCC). METHODS: Expression profile of FOXP3 was a...
Autores principales: | Shi, Jie-Yi, Ma, Li-Jie, Zhang, Ji-Wei, Duan, Meng, Ding, Zhen-Bin, Yang, Liu-Xiao, Cao, Ya, Zhou, Jian, Fan, Jia, Zhang, Xiaoming, Zhao, Ying-Jun, Wang, Xiao-Ying, Gao, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598072/ https://www.ncbi.nlm.nih.gov/pubmed/28903735 http://dx.doi.org/10.1186/s12885-017-3633-6 |
Ejemplares similares
-
TGF-β/Smad Signaling Pathway in Tubulointerstitial Fibrosis
por: Yu, Xiao-Yong, et al.
Publicado: (2022) -
TGF-β1 suppresses the T-cell response in teleost fish by initiating Smad3- and Foxp3-mediated transcriptional networks
por: Zhang, Qian, et al.
Publicado: (2022) -
MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
por: Xu, Juan, et al.
Publicado: (2020) -
Exosomes derived from HCC cells with different invasion characteristics mediated EMT through TGF-β/Smad signaling pathway
por: Qu, Zhen, et al.
Publicado: (2019) -
Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer
por: Xu, Juan, et al.
Publicado: (2023)